JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MR
4151
DELISTED
Montage Resources Corporation Common Stock
MR
| $174K | ﹤0.01% |
44,278
-134,418
| -75% | -$686K |
2015 Q4
18 quarters
|
|
4152
Choiceone Financial
COFS
$494M
| $173K | ﹤0.01% |
+5,860
| New | +$166K |
2020 Q2
0 quarters
|
|
4153
Neurogene
NGNE
$530M
| $173K | ﹤0.01% |
520
+500
| +2,500% | +$130K |
2020 Q1
1 quarter
|
|
|
DISH
4154
PUT
DELISTED
DISH Network Corp.
DISH
| $173K | ﹤0.01% |
5,000
-74,000
| -94% | -$2.06M |
2016 Q4
14 quarters
|
|
|
CTO
4155
CTO Realty Growth
CTO
$761M
| $172K | ﹤0.01% |
16,003
-27,715
| -63% | -$306K |
2017 Q4
10 quarters
|
|
4156
Mastech Digital
MHH
$83.1M
| $172K | ﹤0.01% |
+6,619
| New | +$117K |
2020 Q2
0 quarters
|
|
|
NVMI
4157
Nova
NVMI
$12.5B
| $172K | ﹤0.01% |
3,563
-993
| -22% | -$42.2K |
2018 Q3
7 quarters
|
|
4158
Oil-Dri
ODC
$1.27B
| $172K | ﹤0.01% |
9,936
-4,646
| -32% | -$80.4K |
2017 Q4
10 quarters
|
|
|
ORAN
4159
DELISTED
Orange
ORAN
| $172K | ﹤0.01% |
14,393
-294,256
| -95% | -$3.51M |
2013 Q2
28 quarters
|
|
|
NSCO.WS
4160
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
| – | – |
0
| – | – |
2020 Q1
1 quarter
|
|
|
RRD
4161
DELISTED
RR Donnelley & Sons Co.
RRD
| $170K | ﹤0.01% |
142,710
-1,416,963
| -91% | -$1.72M |
2016 Q4
14 quarters
|
|
|
JPUS
4162
JPMorgan Diversified Return US Equity ETF
JPUS
$455M
| $169K | ﹤0.01% |
2,437
+58
| +2% | +$3.86K |
2015 Q4
18 quarters
|
|
4163
Pacific Biosciences
PACB
$892M
| $169K | ﹤0.01% |
48,940
-1,039,206
| -96% | -$3.54M |
2017 Q4
10 quarters
|
|
|
BRG
4164
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $169K | ﹤0.01% |
20,973
-31,503
| -60% | -$209K |
2015 Q2
20 quarters
|
|
|
SRGA
4165
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $169K | ﹤0.01% |
1,778
-5,229
| -75% | -$390K |
2017 Q4
10 quarters
|
|
|
GTYH
4166
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $169K | ﹤0.01% |
40,595
-27,712
| -41% | -$108K |
2019 Q2
4 quarters
|
|
|
CCRD
4167
DELISTED
CoreCard
CCRD
| $168K | ﹤0.01% |
4,957
-36
| -0.7% | -$1.21K |
2019 Q2
4 quarters
|
|
4168
Global X US Infrastructure Development ETF
PAVE
$13.8B
| $168K | ﹤0.01% |
+10,971
| New | +$153K |
2020 Q2
0 quarters
|
|
4169
Cabaletta Bio
CABA
$353M
| $167K | ﹤0.01% |
15,035
+1,574
| +12% | +$12.1K |
2019 Q4
2 quarters
|
|
4170
Caledonia Mining Corp
CMCL
$471M
| $167K | ﹤0.01% |
9,653
-907
| -9% | -$12.6K |
2019 Q1
5 quarters
|
|
4171
Invesco Preferred ETF
PGX
$3.6B
| $167K | ﹤0.01% |
11,851
+180
| +2% | +$2.52K |
2014 Q4
22 quarters
|
|
4172
Zentalis Pharmaceuticals
ZNTL
$263M
| $167K | ﹤0.01% |
+3,477
| New | +$133K |
2020 Q2
0 quarters
|
|
|
TELL
4173
DELISTED
Tellurian Inc.
TELL
| $167K | ﹤0.01% |
145,408
-186,191
| -56% | -$236K |
2017 Q4
10 quarters
|
|
4174
CEL-SCI Corp
CVM
$42.6M
| $166K | ﹤0.01% |
371
+16
| +5% | +$6.57K |
2019 Q2
4 quarters
|
|
4175
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.73B
| $166K | ﹤0.01% |
4,250
| – | – |
2017 Q2
12 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.